NOVARTIS N 2. LINIENOVARTIS N 2. LINIENOVARTIS N 2. LINIE

NOVARTIS N 2. LINIE

No trades
See on Supercharts
Market capitalization
‪168.06 B‬CHF
‪13.34 B‬CHF
‪40.83 B‬CHF
‪1.75 B‬
Beta (1Y)
0.63

About NOVARTIS N 2. LINIE

CEO
Vasant Narasimhan
Headquarters
Basel
Employees (FY)
‪76.06 K‬
Founded
1996
ISIN
CH0038459415
FIGI
BBG0027FDTP9
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of NOVNEE is 84.72 CHF — it has decreased by 0.16% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange NOVARTIS N 2. LINIE stocks are traded under the ticker NOVNEE.
NOVNEE stock is 0.84% volatile and has beta coefficient of 0.63. Check out the list of the most volatile stocks — is NOVARTIS N 2. LINIE there?
Yes, you can track NOVARTIS N 2. LINIE financials in yearly and quarterly reports right on TradingView.
NOVNEE stock has fallen by 1.98% compared to the previous week, the month change is a 0.92% fall, over the last year NOVARTIS N 2. LINIE has showed a 3.80% decrease.
NOVNEE net income for the last quarter is ‪7.52 B‬ CHF, while the quarter before that showed ‪1.56 B‬ CHF of net income which accounts for 383.56% change. Track more NOVARTIS N 2. LINIE financial stats to get the full picture.
Today NOVARTIS N 2. LINIE has the market capitalization of ‪165.36 B‬, it has increased by 0.76% over the last week.
No, NOVNEE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NOVNEE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVARTIS N 2. LINIE stock right from TradingView charts — choose your broker and connect to your account.
NOVNEE reached its all-time high on Jul 20, 2015 with the price of 103.03 CHF, and its all-time low was 47.88 CHF and was reached on Mar 19, 2008.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has ‪76.06 K‬ employees. See our rating of the largest employees — is NOVARTIS N 2. LINIE on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOVARTIS N 2. LINIE technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOVARTIS N 2. LINIE stock shows the sell signal. See more of NOVARTIS N 2. LINIE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVARTIS N 2. LINIE EBITDA is ‪19.31 B‬ CHF, and current EBITDA margin is 44.33%. See more stats in NOVARTIS N 2. LINIE financial statements.